Phosphoproteomic Identification of Vasopressin-Regulated Protein Kinases in Collecting Duct Cells

Abstract

Background and PurposeThe peptide hormone vasopressin regulates water transport in the renal collecting duct largely via the V2 receptor, which triggers a cAMP-mediated activation of a protein kinase A (PKA)-dependent signaling network. The protein kinases downstream from PKA have not been fully identified or mapped to regulated phosphoproteins.Experimental ApproachWe carried out systems-level analysis of large-scale phosphoproteomic data quantifying vasopressin-induced changes in phosphorylation in aquaporin-2-expressing cultured collecting duct cells (mpkCCD). Quantification was done using stable isotope labeling (SILAC method).Key Results9640 phosphopeptides were quantified. Stringent statistical analysis identified significant changes in response to vasopressin in 429 of these phosphopeptides. The corresponding phosphoproteins were mapped to known vasopressin-regulated cellular processes. The vasopressin-regulated sites were classified according to the sequences surrounding the phosphorylated amino acids giving 11 groups distinguished predominantly by the amino acids at positions +1, −3, −2 and −5 relative to the phosphorylated amino acid. Among the vasopressin-regulated phosphoproteins were 25 distinct protein kinases. Among these, six of them plus PKA appeared to account for phosphorylation of more than 80% of the 313 vasopressin-regulated phosphorylation sites. The six downstream kinases were salt-inducible kinase 2 (Sik2), cyclin-dependent kinase 18 (PCTAIRE-3, Cdk18), calmodulin-dependent kinase kinase 2 (Camkk2), protein kinase D2 (Prkd2), mitogen-activated kinase 3 (ERK1; Mapk3), and myosin light chain kinase (Mylk).Conclusion and ImplicationsIn V2 receptor-mediated signaling, PKA is at the head of a complex network that includes at least 6 downstream vasopressin-regulated protein kinases that are prime targets for future study. The extensive phosphoproteomic data generated in this study is provided as a web-based data resource for future studies of G-protein coupled receptors.

Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective

“…It has been observed that platelet activations, endothelial dysfunction and thrombosis in SARS-CoV-2 are due to activation of mitogen-activated protein kinase (MAPK) leading to pulmonary micro-vascular thrombosis and progression of ALI/ARDS [58] . Notably, AVP triggers MAPK-induced endothelial dysfunction with direct effect for release of clotting factors [59] , [60] . Remarkably, administration of AVP reduces development of ALI [61] however, Barcroft et al, illustrated in a case-report study that intramyometrial infiltration of AVP during laparoscopic myomyectomy leads to acute pulmonary edema and coronary vasospasm [62] .…”

Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus

“…The downstream targets of PKA that mediate PKA-induced AQP2-S261 dephosphorylation and AQP2-S269 phosphorylation remain unknown. Quantitative phosphoproteome analysis of mpkCCD cell lines in the presence or absence of vasopressin revealed that six protein kinases (Sik2, Cdk18, Camkk2, Prkd2, Mapk3, and Mylk) were involved in the vasopressin/cAMP/PKA signaling pathway [ 18 ]. In addition to kinases, phosphatases in the vasopressin signaling pathway contribute to AQP2 phosphorylation [ 19 ].…”